Orahn Preiss-Bloom, Founder and Chief Innovation Officer
Orahn is the Founder and Chief Innovation Officer at OSSIO. Previously, as founder and COO/CTO of LifeBond, Orahn developed two biosurgical product families to commercial stage and raised $60M, including from Johnson & Johnson Development Corporation. Prior, he was a biomechanics researcher at IDF Institute for Military Physiology and at Columbia University NY, Dept. of Orthopedic Surgery. Orahn has an M.Sc. in biomedical engineering from the Technion, Israel Institute of Technology.
Metal implants can cause unwanted hardware removal surgeries, associated complications, allergic reactions, and an unnatural healing environment for patients. OSSIOfiber® offers a bio-integrative alternative to the potential pain, anxiety, and costs associated with metallic fixation.
Keep In Touch With Us
® 2020 OSSIO and OSSIOfiber are registered trademarks of OSSIO. All rights reserved.